Suppressing the function of ERCC1–XPF is very important to increase the effectiveness of chemotherapy and radiotherapy in cancer because both chemotherapy and radiotherapy cause cancer cell death through DNA damage, DNA cross-link, and DNA break. This evidence concerns the gene ERCC1 and cancer.